Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

JOURNAL ARTICLE published July 2019 in Annals of Oncology

Authors: Y.J.L. Jansen | E.A. Rozeman | R. Mason | S.M. Goldinger | M.H. Geukes Foppen | L. Hoejberg | H. Schmidt | J.V. van Thienen | J.B.A.G. Haanen | L. Tiainen | I.M. Svane | S. Mäkelä | T. Seremet | A. Arance | R. Dummer | L. Bastholt | M. Nyakas | O. Straume | A.M. Menzies | G.V. Long | V. Atkinson | C.U. Blank | B. Neyns